Delivery Order SPE2DB22D9124-SPE2DB25FP4KA
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,041.56 to DMS Pharmaceutical Group Inc. for the supply of Mirena 52 mg systems. This contract, issued on July 14, 2025, with an ultimate completion date of August 4, 2025, represents a firm fixed-price delivery order with no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, will perform this delivery order at its Park Ridge...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $4,166.24 to DMS Pharmaceutical Group Inc. for the supply of Mirena 52 mg systems. The award, issued on August 1, 2025, with an ultimate completion date of August 22, 2025, represents a delivery order under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract (IDC) with DLA valued at approximately $500 million through November 2026. The delivery order carries no set-aside designation,...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Mirena 52 mg systems. This firm fixed-price delivery order, valued at $4,166.24, was awarded on June 2, 2025, with an ultimate completion date of June 24, 2025. The contract utilizes no set-aside designation and represents a single delivery order under DMS Pharmaceutical Group's larger...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $1,562.31 to DMS Pharmaceutical Group Inc. for Mirena 52 mg systems, with an ultimate completion date of June 24, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The delivery order will be performed at the contractor's location in Park Ridge, Illinois. This delivery order is issued under DMS...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,415.40 to DMS Pharmaceutical Group Inc. on July 28, 2025, for the supply of Mirena 52 mg systems. The award, which carries an ultimate completion date of August 18, 2025, utilizes a firm fixed-price contract type with no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform this delivery order at its Illinois facility. The...
- The Defense Logistics Agency awarded a $5,207.70 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for Mirena 52 mg systems, with an ultimate completion date of September 3, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The delivery order represents a specific product requisition issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $3,124.68 to DMS Pharmaceutical Group Inc. for Mirena 52 mg systems, with an ultimate completion date of September 15, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The delivery order falls under the company's larger Indefinite Delivery Contract with DLA valued at approximately $500 million...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $26,038.50 to DMS Pharmaceutical Group Inc. for Mirena 52 mg systems. DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The delivery order is scheduled for ultimate completion on October 8, 2025, with performance taking place at the contractor's Park Ridge facility. Mirena is a hormonal intrauterine...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,019.25 to DMS Pharmaceutical Group Inc. for Mirena 52 mg systems, with an ultimate completion date of September 26, 2025. This firm fixed-price delivery order represents a purchase under DLA's larger Indefinite Delivery Contract (IDC) with DMS Pharmaceutical Group, valued at approximately $500 million and valid through November 2026. The award carries no set-aside designation, allowing the woman-owned small business...
- The Defense Logistics Agency (DLA) awarded a $5,603.44 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Mirena 52 mg systems. This delivery order, issued on August 26, 2025, with an ultimate completion date of September 17, 2025, is issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract (IDC) with the DLA valued at $499,999,999 through...
- SPE2DB22D9124Indefinite Delivery Contract
- SPE2DB22D9124-SPE2DB25FP4KADelivery Order
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $1,041.56 to DMS Pharmaceutical Group Inc. for 52 mg Mirena systems, with an ultimate completion date of October 7, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was selected without a set-aside designation. This delivery order represents a single transaction under the company's larger Indefinite Delivery Contract (IDC) with DLA under the SPE2DB program, valued at approximately $500 million and extending through November 2026. The Mirena delivery order supports DLA's pharmaceutical supply chain operations serving military health facilities nationwide. DMS Pharmaceutical Group's core business encompasses distribution of branded and generic prescription drugs, biologics, over-the-counter medications, and medical consumables to federal healthcare systems. The company has established itself as a significant supplier within the Department of Defense pharmaceutical procurement landscape, consistently delivering specialized medical products ranging from contraceptive devices to oncology treatments and vaccines through its comprehensive IDC portfolio with DLA.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 9/16/25 |